<DOC>
	<DOC>NCT00991458</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of Cyclosporine 0.005% and 0.010% eye drops administered twice daily before and following LASIK surgery.</brief_summary>
	<brief_title>Study of Cyclosporine in Post-LASIK Patients</brief_title>
	<detailed_description />
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Patient is scheduled for bilateral LASIK surgery Patient is in good general health Eye glasses prescription of 1 to 8 Significant Dry Eye Presence of eye disease Uncontrolled systemic disease Previous use of RESTASISÂ®</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>